Veterinary Medicine Information website

VANGUARD PLUS 7

Authorised
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine distemper virus, strain N-CDV, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
Download as PDF

Product identification

Medicine name:
VANGUARD PLUS 7
Active substance:
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine distemper virus, strain N-CDV, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
Target species:
  • Dog
  • Dog
Route of administration:
  • Subcutaneous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parainfluenza virus, strain NL-CPI-5, Live
    6.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain N-CDV, Live
    3.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain Manhattan, Live
    3.20
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain NL-35-D, Live
    7.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
    40.00
    Protective Dose
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
    40.00
    Protective Dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Available in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 140019
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 19/11/2024
Download